These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12877935)
81. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360 [TBL] [Abstract][Full Text] [Related]
82. Antagonism of the mGlu5 agonist 2-chloro-5-hydroxyphenylglycine by the novel selective mGlu5 antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) in the thalamus. Salt TE; Binns KE; Turner JP; Gasparini F; Kuhn R Br J Pharmacol; 1999 Jul; 127(5):1057-9. PubMed ID: 10455248 [TBL] [Abstract][Full Text] [Related]
83. [(3)H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5. Gasparini F; Andres H; Flor PJ; Heinrich M; Inderbitzin W; Lingenhöhl K; Müller H; Munk VC; Omilusik K; Stierlin C; Stoehr N; Vranesic I; Kuhn R Bioorg Med Chem Lett; 2002 Feb; 12(3):407-9. PubMed ID: 11814808 [TBL] [Abstract][Full Text] [Related]
84. Changes in mGlu5 receptor expression in the basal ganglia of reserpinised rats. Ismayilova N; Verkhratsky A; Dascombe MJ Eur J Pharmacol; 2006 Sep; 545(2-3):134-41. PubMed ID: 16890937 [TBL] [Abstract][Full Text] [Related]
85. mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity. Wu CS; Jew CP; Sun H; Ballester Rosado CJ; Lu HC Psychopharmacology (Berl); 2020 Feb; 237(2):345-361. PubMed ID: 31646346 [TBL] [Abstract][Full Text] [Related]
86. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice. Storto M; Ngomba RT; Battaglia G; Freitas I; Griffini P; Richelmi P; Nicoletti F; Vairetti M J Hepatol; 2003 Feb; 38(2):179-87. PubMed ID: 12547406 [TBL] [Abstract][Full Text] [Related]
87. Endogenous activation of mGlu5 metabotropic glutamate receptors supports self-renewal of cultured mouse embryonic stem cells. Cappuccio I; Spinsanti P; Porcellini A; Desiderati F; De Vita T; Storto M; Capobianco L; Battaglia G; Nicoletti F; Melchiorri D Neuropharmacology; 2005; 49 Suppl 1():196-205. PubMed ID: 16023153 [TBL] [Abstract][Full Text] [Related]
88. Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies. Bennett KA; Sergeev E; MacSweeney CP; Bakker G; Cooper AE J Pharmacol Exp Ther; 2021 Apr; 377(1):157-168. PubMed ID: 33541889 [TBL] [Abstract][Full Text] [Related]
89. Indomethacin, a nonselective cyclooxygenase inhibitor, does not interact with MTEP in antidepressant-like activity, as opposed to imipramine in CD-1 mice. Stachowicz K Eur J Pharmacol; 2020 Dec; 888():173585. PubMed ID: 32971092 [TBL] [Abstract][Full Text] [Related]
90. In vitro microsomal metabolic studies on a selective mGluR5 antagonist MTEP: characterization of in vitro metabolites and identification of a novel thiazole ring opening aldehyde metabolite. Yang X; Chen W Xenobiotica; 2005 Aug; 35(8):797-809. PubMed ID: 16278192 [TBL] [Abstract][Full Text] [Related]
91. Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures. Domin H; Kajta M; Smiałowska M Pharmacol Rep; 2006; 58(6):846-58. PubMed ID: 17220542 [TBL] [Abstract][Full Text] [Related]
92. In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. DeLorenzo C; Milak MS; Brennan KG; Kumar JS; Mann JJ; Parsey RV Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1083-94. PubMed ID: 21279350 [TBL] [Abstract][Full Text] [Related]
93. Use of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists. Miller TR; Milicic I; Bauch J; Du J; Surber B; Browman KE; Marsh K; Cowart M; Brioni JD; Esbenshade TA Br J Pharmacol; 2009 May; 157(1):139-49. PubMed ID: 19413577 [TBL] [Abstract][Full Text] [Related]